Zobrazeno 1 - 10
of 428
pro vyhledávání: '"Hiroki, Yokoyama"'
Autor:
Tomoya Mita, Naoto Katakami, Hidenori Yoshii, Tomio Onuma, Hideaki Kaneto, Takeshi Osonoi, Toshihiko Shiraiwa, Tetsuyuki Yasuda, Yutaka Umayahara, Tsunehiko Yamamoto, Hiroki Yokoyama, Nobuichi Kuribayashi, Hideaki Jinnouchi, Masahiko Gosho, Iichiro Shimomura, Hirotaka Watada
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract We previously reported in the study of preventive effects of alogliptin on diabetic atherosclerosis (SPEAD-A) that alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, attenuated the progression of carotid atherosclerosis in subjects with
Externí odkaz:
https://doaj.org/article/504f541633734e1b9dd4929a53e657fb
Autor:
Ryotaro Bouchi, Takehiro Sugiyama, Atsushi Goto, Mitsuru Ohsugi, Narihito Yoshioka, Hideki Katagiri, Tomoya Mita, Yushi Hirota, Hiroshi Ikegami, Munehide Matsuhisa, Eiichi Araki, Hiroki Yokoyama, Masae Minami, Katsuya Yamazaki, Hideaki Jinnouchi, Hiroki Ikeda, Hitomi Fujii, Miyuki Nogawa, Masahiro Kaneshige, Kengo Miyo, Kohjiro Ueki
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 8, Pp 994-1004 (2023)
ABSTRACT Aims/Introduction To investigate whether the COVID‐19 pandemic affected behavioral changes and glycemic control in patients with diabetes and to conduct a survey of telemedicine during the pandemic. Materials and Methods In this retrospect
Externí odkaz:
https://doaj.org/article/4c3540708a4f456aa08824d59ddc453f
Autor:
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, Toshihiko Shiraiwa, Tetsuyuki Yasuda, Yosuke Okada, Akira Kurozumi, Masahiro Hatazaki, Hideaki Kaneto, Takeshi Osonoi, Tsunehiko Yamamoto, Nobuichi Kuribayashi, Kazuhisa Maeda, Hiroki Yokoyama, Keisuke Kosugi, Kentaro Ohtoshi, Isao Hayashi, Satoru Sumitani, Mamiko Tsugawa, Kayoko Ryomoto, Ken Kato, Tadashi Nakamura, Satoshi Kawashima, Yasunori Sato, Hirotaka Watada, Iichiro Shimomura, the UTOPIA study investigators
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-15 (2023)
Abstract Background This study aimed to assess the long-term effects of tofogliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes lacking an appare
Externí odkaz:
https://doaj.org/article/8358aaeab0374c86b4c5f65e4528a3a5
Autor:
Megumi Oshima, Yasunori Iwata, Tadashi Toyama, Shinji Kitajima, Akinori Hara, Norihiko Sakai, Miho Shimizu, Kengo Furuichi, Masakazu Haneda, Tetsuya Babazono, Hiroki Yokoyama, Kunitoshi Iseki, Shinichi Araki, Toshiharu Ninomiya, Shigeko Hara, Yoshiki Suzuki, Masayuki Iwano, Eiji Kusano, Tatsumi Moriya, Hiroaki Satoh, Hiroyuki Nakamura, Hirofumi Makino, Takashi Wada
Publikováno v:
Journal of Diabetes, Vol 15, Iss 3, Pp 246-254 (2023)
Abstract Background This study investigated the sex differences in the risk of end‐stage kidney disease (ESKD) and mortality, as well as the effect modification of sex on associated factors in patients with type 2 diabetes. Methods This multicenter
Externí odkaz:
https://doaj.org/article/8d44beca152a467188bf2c623f65f140
Autor:
Ken‐ichi Tsuchida, Shinji Taneda, Isao Yokota, Kazufumi Okada, Yoshio Kurihara, Hiroki Yokoyama, Masahiro Iwamoto, Katsuya Yamazaki, Yasushi Ishigaki, Naoki Manda, Hiroshi Maegawa, Japan Diabetes Clinical Data Management Study Group (JDDM study group)
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 11, Pp 1834-1841 (2022)
ABSTRACT Aims/Introduction Few studies have investigated the renoprotective effect of glucagon‐like peptide‐1 (GLP‐1) receptor in patients with chronic kidney disease (CKD). This study evaluated the effect of dulaglutide 0.75 mg on renal functi
Externí odkaz:
https://doaj.org/article/d55ac9c50b4e454eabde6b1f67ff136e
Autor:
Hiroto Ishii, Tomohiko Sato, Miyuki Ishibashi, Hiroki Yokoyama, Takeshi Saito, Tetsunori Tasaki, Shingo Yano
Publikováno v:
International Journal of Infectious Diseases, Vol 122, Iss , Pp 755-757 (2022)
We report the first case of immune complex type hemolytic anemia by initial micafungin administration that was given as prophylaxis to a 42-year-old Japanese man receiving chemotherapy for primary amyloidosis. The few cases found in the literature we
Externí odkaz:
https://doaj.org/article/ca4305708ec649d3acbca98990b12106
Autor:
Yuriko Takeda, Koshi Ota, Ayuka Kondo, Tomonobu Nishii, Naoya Onishi, Hiroki Yokoyama, Kazuma Yamakawa, Akira Takasu
Publikováno v:
IDCases, Vol 31, Iss , Pp e01667- (2023)
Background: Bifidobacterium breve is an obligate anaerobic gram-positive bacillus mainly found in the gastrointestinal tract of human infants. Few cases of necrotizing fasciitis caused by B. breve have been reported. Case presentation: A 42-year-old
Externí odkaz:
https://doaj.org/article/8bf36eab9c1d4316956caced8a5dde16
Autor:
Chiaki Hara, Masafumi Suga, Hiroki Yokoyama, Haruki Nakayama, Akihiko Inoue, Shigenari Matsuyama, Satoshi Ishihara
Publikováno v:
Trauma Case Reports, Vol 42, Iss , Pp 100700- (2022)
The Hybrid Emergency Room System (HERS) allows clinicians to perform life-saving procedures without having to transfer patients. Several studies have reported the effectiveness of the HERS in the treatment of blunt trauma patients. However, the use o
Externí odkaz:
https://doaj.org/article/57540b566137459c82464491f229bb07
Publikováno v:
Japan Architectural Review, Vol 5, Iss 1, Pp 3-19 (2022)
Abstract The biaxially symmetric column induces torsional moment owing to the bending–torsion interaction when the top of the column is given horizontal displacement in the two directions of the principal axes of the cross section and the rotation
Externí odkaz:
https://doaj.org/article/885bfaa44f9041499384330e61e4ebfd
Autor:
Noriharu Yagi, Ichiro Komiya, Keiko Arai, Mariko Oishi, Yoshihide Fukumoto, Shinichirou Shirabe, Hiroki Yokoyama, Katsuya Yamazaki, Hidekatsu Sugimoto, Hiroshi Maegawa, Japan Diabetes Clinical Data Management Study Group (JDDM study group),
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 1, Pp 65-73 (2022)
Abstract Aims/Introduction Type 2 diabetes mellitus is caused by a relative imbalance between insulin secretion and sensitivity related to the body mass index (BMI). Seven categories of oral antidiabetic drugs (OADs) are available in Japan. It is imp
Externí odkaz:
https://doaj.org/article/ec12e679327a4f17b385fb79e7b6b02b